Intravesical Oncoviral Therapy for Bladder Cancer

Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer

“…Finally, the success of BCG and adenovirus therapy for NMIBC demonstrates the sensitivity of BC to viro-immunotherapy. 24,29,32 Thus, in this report, we provide preclinical and translational immune response evidence for the use of oncolytic VSVd51-hGM-CSF for the treatment of BC.…”